Proven across a broad range of complex cases, the versatility of the GORE® VIABAHN® Endoprosthesis with Heparin Bioactive Surface* enables you to deliver high patency and durable outcomes to minimize interventions for your patients.

durable clinical study outcomes in complex cases
proven to significantly reduce reinterventions
high patency even in the most challenging disease
A leader among stent grafts with multiple indications for maximum versatility
unparalleled performance through decades of partnership with clinicians across the globe
over 2300 scientific publications
over 5650 hospitals using GORE VIABAHN Endoprosthesis
Over 1,000,000 implanted in patients worldwide

Performance evolution through collaboration

The VIABAHN® Device is a leader among stent grafts. Decades of partnership with clinicians around the globe has resulted in unparalleled performance across multiple indications. The VIABAHN® Device features:

  • Lengths up to 25 cm
  • Low profile design
  • Multiple FDA approved indications for use
  • Radiopaque markers
  • Proven CBAS Heparin Surface technology§


*  As used by Gore, Heparin Bioactive Surface refers to Gore’s proprietary CBAS Heparin Surface.

 GORE® VIABAHN® Endoprosthesis. W. L. Gore & Associates website. Accessed July 29, 2020.

Data on file 2020; W. L. Gore & Associates, Inc.; Flagstaff, AZ.

§  CBAS Heparin Surface. W. L. Gore & Associates Web site. Accessed July 30, 2018.
  1. Piazza M, Squizzato F, Dall'Antonia A, et al. Outcomes of self expanding PTFE covered stent versus bare metal stent for chronic iliac artery occlusion in matched cohorts using propensity score modelling. European Journal of Vascular & Endovascular Surgery 2017;54(2):177-185.

GORE VIABAHN Endoprosthesis - Heparin Bioactive Surface